ExoCoBio

Private

SeoulHealthcare & Life Scienceshttp://exocobio.com/

Last Round

Series C

Aug 25, 2020

Total Funding Raised

$47M

Company Overview

ExoCoBio is a biotechnology company that develops exosome-based biopharmaceuticals and regenerative aesthetic products for skin and hair.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

exosome therapyregenerative aestheticsstem cell exosomescosmeceuticalsmedical aestheticsskin rejuvenationhair restorationanti-aging treatmentExoSCRTmedical grade skincareASCE+exosome isolationK-beautyGMP manufacturinglyophilized exosomesbiopharmaceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExoCoBio Comps

Public and private peers based on sector, stage, and business model.

ExoCoBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ExoCoBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Aug 25, 2020
Series B	Sep 12, 2018
Series A	May 4, 2017

View all Funding Rounds

ExoCoBio Investors

Notable investors and investment history

ExoCoBio investors
Investor	Rounds
InterVest	Series B
KDB Capital Corp	Series B
K2 Investment Partners	Series C, Series B
Csquared Global Asset Management	Series B
Focus Assets Management	Series C
TS Investment	Series B
SBI Investment Korea	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 22, 2026
Grew 23% QoQ, from 22 to 27 employees.
Jan 26, 2026
Monthly visitors increased 148% MoM, reaching 38.8K.

View all signals

ExoCoBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ExoCoBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ExoCoBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range28

Year Founded2017

Last FundingAug 25, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.